Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1985 Dec;20(3):209–213. doi: 10.1007/BF00205578

Effect of melphalan in vitro on induction of murine suppressor T cells by ConA

Rachel Ophir 1, Shlomo Ben-Efraim 1
PMCID: PMC11038141  PMID: 2933142

Abstract

The effect of treatment with melphalan in vitro on the activity of spleen cells from BALB/c mice was investigated. Incubation of spleen cells with 1.5–5 μg melphalan/1×107 inhibited subsequent mitogenic stimulation by ConA or PHA and the allogeneic response of BALB/c spleen cells against C57B1 target spleen cells. Incubation of spleen cells with ConA led to induction of suppressor T cells which when added to fresh cultures inhibited the allogeneic response. Preincubation of spleen cells with melphalan even at low concentrations (0.15–0.5 μg 1×107 cells) which do not directly affect mitogenic stimulation or allogeneic response partially inhibited the generation of suppressor T cells by ConA. Treatment with melphalan had no effect on already induced suppressor T cells as shown by incubation of spleen cells with melphalan (0.15–5 μg/1×107 cells) after incubation with ConA. Addition of cells treated with melphalan alone (without ConA) to fresh cultures led to an increase in the allogeneic response.

Keywords: Cancer Research, Melphalan, Spleen Cell, Fresh Culture, Mitogenic Stimulation

References

  • 1.Ben-Efraim S, Bocian RC, Mokyr MB, Dray S. Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytomas tumor growth. Cancer Immunol Immunother. 1983;15:101. doi: 10.1007/BF00199699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ben-Efraim S, Komlos L, Notmann J, Hart J, Halbrecht I. In vitro selective effect of melphalan on human T-cell populations. Cancer Immunol Immunother. 1985;19:53. doi: 10.1007/BF00199312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bocian RC, Ben-Efraim S, Dray S, Mokyr MB. Melphalan-mediated potentiation of antitumor responsiveness of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor. Cancer Immunol Immunother. 1984;18:41. doi: 10.1007/BF00205398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Diamanstein T, Klos M, Hahn H, Kaufman SHE. Direct in vitro evidence for different susceptibilities to 4-hydroxyperoxycyclophosphamide of antigen-primed T cells regulating humoral and cell-mediated immune response to sheep erythrocytes: a possible explanation for the inverse action of cyclophosphamide on humoral and cell-mediated immune resonse. J Immunol. 1981;126:1717. [PubMed] [Google Scholar]
  • 5.Dray S, Mokyr MB (1985) Immunomodulation by cyclophosphamide and its effect on eradication of established tumors. In: Fudenberg H, Ambrogy F (eds) Frontiers in Immunomodulation. Plenum Press New York, (in press)
  • 6.Glaser M. Augmentation of specific immune response against syngeneic SV-40-induced sarcoma in mice by depeletion of suppressor T cells with cyclophosphamide. Cell Immunol. 1979;48:339. doi: 10.1016/0008-8749(79)90128-x. [DOI] [PubMed] [Google Scholar]
  • 7.Hengst JCD, Mokyr MB, Dray S. Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice. Cancer Res. 1980;40:2135. [PubMed] [Google Scholar]
  • 8.Hengst JCD, Mokyr MB, Dray S. Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors. Cancer Res. 1981;41:2163. [PubMed] [Google Scholar]
  • 9.Klayman A, Drucker I, Manor J, Ben-Efraim S. In vitro effects of 4-hydroperoxycyclophosphamide on concanavalin A induced human suppressor T cells. Cancer Immunol Immunother. 1984;18:113. doi: 10.1007/BF00205744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.L'Age-Stehr J, Diamantstein T. Induction of autoreactive T lymphocytes and their suppressor cells by cylophosphamide. Nature. 1978;271:663. doi: 10.1038/271663a0. [DOI] [PubMed] [Google Scholar]
  • 11.North RJ. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J Exp Med. 1977;55:1063. doi: 10.1084/jem.155.4.1063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.North RJ. Adoptive immunotherapy. Adv Immunol. 1984;35:89. doi: 10.1016/s0065-2776(08)60575-1. [DOI] [PubMed] [Google Scholar]
  • 13.Oppenheim JJ, Rosenstreich DL. Lymphocyte transformation: Utilization of automatic harvesters. In: Bloom BR, David JR, editors. In vitro methods in cell-mediated and tumor immunity. San Francisco, London: Academic Press New York; 1976. p. 593. [Google Scholar]
  • 14.Osawa H, Diamantstein T. A rat monoclonal antibody that binds pecifically to mouse T lymphoblasts and inhibits IL-2-receptor functions: A putative anti-IL-2-receptor antibody. J Immunol. 1984;132:2445. [PubMed] [Google Scholar]
  • 15.Ozer H, Cowens JW, Colvin M, Nussbaum-Blumenson A, Sheedy D. In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration. J Exp Med. 1982;155:276. doi: 10.1084/jem.155.1.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Shand FL, Orme IM, Ivanyi J. The induction of suppressor T cells by concanavalin A is independent of cellular proliferation and protein synthesis. Scand J Immunol. 1980;12:223. doi: 10.1111/j.1365-3083.1980.tb00062.x. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES